Technology | April 08, 2013

First new software aims to better Aplio 500 and 300

To expand imaging capabilities and improve productivity, Toshiba America Medical Systems, Inc. introduces Innovation 2013, new FDA-cleared software advancements for the Aplio 500 and Aplio 300 ultrasound systems.


April 8, 2013 — Toshiba America Medical Systems, Inc. has introduced Innovation 2013, new U.S. Food and Drug Administration (FDA)-cleared software advancements for the Aplio 500 and Aplio 300 ultrasound systems.

Innovation 2013 offers the latest enhancements in ultrasound imaging, including B-Mode and Color Doppler, with additional features as options:

• Luminance: A 4-D rendering and lighting technique producing stellar fetal images, Luminance can better visualize the fetal face and other anatomical structures by applying color and illumination to enhance features.

• New transducers: The PVT-781VT (3–11 MHz) is a high-resolution, endocavitary transducer designed for producing superb endovaginal and prostate imaging. This transducer supports the Aplio 500’s Smart Fusion technology, which synchronizes computed tomography (CT) or magnetic resonance (MR) with ultrasound images on a single screen. The PLT-1005BT (5–14 MHz) is a high-frequency, high-resolution linear array transducer ideal for small-parts imaging, including breast. This transducer has a wide aperture of 58 millimeters.

• Workflow enhancements: Next-generation Quick Assist Protocols, designed to automate workflow, increase consistency and standardize exams, allow for greater focus on the patient.

All existing Aplio 500 and 300 customers will receive the Innovation 2013 software upgrade complimentary, excluding new options.

The systems also offer:

• Fly Thru: An industry first, Fly Thru uses 4-D ultrasound to “fly through” interiors of fluid-filled ducts and vessels for better exploration of lesions and masses, and to assist in planning interventional procedures.

• Smart Fusion: Combines the best in imaging by synchronizing CT or MR with ultrasound to locate hard-to-find lesions and aid in ultrasound-guided biopsies.

“Aplio 500 and 300 offer advanced visualization capabilities and enhanced ergonomics for more accurate diagnoses and faster patient exams,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba.

For more information: www.medical.toshiba.com


Related Content

News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 27, 2026 — Siemens Healthineers and World Athletics have joined forces to inform medical teams how point-of-care ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 26, 2026 — Researchers at the University of Arizona were awarded up to $1.8 million by the Advanced Research ...

Time January 26, 2026
arrow
News | Focused Ultrasound Therapy

Dec. 19, 2025 — Washington University in St. Louis (WashU) has been recognized as a Focused Ultrasound Center of ...

Time December 23, 2025
arrow
News | RSNA 2025

Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North ...

Time November 03, 2025
arrow
News | Cardiac Imaging

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Time October 27, 2025
arrow
News | Ultrasound Women's Health

Sept. 30, 2025 — Sona, the first free, HIPAA-compliant platform that securely delivers ultrasound images directly to ...

Time October 02, 2025
arrow
News | Women's Health

Sept. 15, 2025 — GE HealthCare has launched the Voluson Performance series, the latest addition to its women’s health ...

Time September 15, 2025
arrow
News | Cardiac Imaging

Aug. 29, 2025 — GE HealthCare has launched Vivid Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ...

Time August 29, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Aug. 12, 2025 —Sonic Incytes Medical Corp, has announced that the U.S. Food and Drug Administration (FDA) has granted ...

Time August 15, 2025
arrow
Subscribe Now